NCT04218513View on ClinicalTrials.gov

Drug-drug Interaction Study Between Edaravone and 2-Aminoethanesulfonic Acid in Compound Edaravone Injection

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 10, 2019

Primary Completion Date

May 31, 2019

Study Completion Date

May 31, 2019

Conditions
Drug-drug Interaction
Interventions
DRUG

Compound Edaravone Injection

30 min intravenous infusion

DRUG

Edaravone Injection

30 min intravenous infusion

DRUG

2-Aminoethanesulfonic Acid Injection

30 min intravenous infusion

Trial Locations (1)

100050

Beijing Tiantan Hospital, Capital Medical University, Beijing

All Listed Sponsors
lead

Nanjing Yoko Biomedical Co., Ltd.

INDUSTRY

NCT04218513 - Drug-drug Interaction Study Between Edaravone and 2-Aminoethanesulfonic Acid in Compound Edaravone Injection | Biotech Hunter | Biotech Hunter